Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure.
about
Natriuretic peptides for acute heart failureNatriuretic peptides for acute heart failureEfficacy and safety of nesiritide in patients with decompensated heart failure: a meta-analysis of randomised trialsAngiotensin receptor-neprilysin inhibitors: clinical potential in heart failure and beyondProspective development and validation of a model to predict heart failure hospitalisationInotropes do not increase mortality in advanced heart failureNesiritide in acute decompensated heart failure: current status and future perspectivesB-type natriuretic peptide: the level and the drug--partners in the diagnosis of congestive heart failure.Genetic and nongenetic factors influencing pharmacokinetics of B-type natriuretic peptide.Current treatment options for early management in acute decompensated heart failure.Nesiritide: a new drug for the treatment of decompensated heart failure.Genetic variation in the natriuretic peptide system and heart failure.Nesiritide: a novel approach for acute heart failure.Inotrope use and outcomes among patients hospitalized for heart failure: impact of systolic blood pressure, cardiac index, and etiologyComparative effects of recombinant human brain natriuretic peptide and dobutamine on acute decompensated heart failure patients with different blood BNP levelsTreatment of congestive heart failure a neuroendocrine disorder.Lack of evidence for intravenous vasodilators in ED patients with acute heart failure: a systematic reviewProbenecid as a noninjurious positive inotrope in an ischemic heart disease murine model.Acute decompensated heart failure: a contemporary approach to pharmacotherapeutic management.Management of acute decompensated heart failure in the emergency department.The evolving role of nesiritide in advanced or decompensated heart failure.Guidelines for acute decompensated heart failure treatment.Hypotension during hospitalization for acute heart failure is independently associated with 30-day mortality: findings from ASCEND-HFPreliminary experience with nesiritide in the pediatric population.Inotropic agents use in patients hospitalized with acute decompensated heart failure: a retrospective analysis from a 22-year registry in a Middle-Eastern Country (1991-2013).BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases.Brain natriuretic peptide in the contemporary management of congestive heart failure.Acutely decompensated congestive heart failure: new therapies for an old problem.The benefits of early vasoactive therapy in the treatment of acute decompensated heart failure.Cardiovascular and metabolic effects of natriuretic peptides.Retraction. rhBNP therapy can improve clinical outcomes and reduce in-hospital mortality compared with dobutamine in heart failure patients: a meta-analysis.Nesiritide: harmful or harmless?Prolonged effects of B-type natriuretic peptide infusion on cardiac remodeling after sustained myocardial injury.Local renal delivery of a natriuretic peptide a renal-enhancing strategy for B-type natriuretic peptide in overt experimental heart failure.Modern approach to the treatment of decompensated heart failure.B-type natriuretic peptides in heart failure.Clinical trials in acute heart failure: simpler solutions to complex problems. Consensus document arising from a European Society of Cardiology cardiovascular round-table think tank on acute heart failure, 12 May 2009.Dobutamine Therapy is Associated with Worse Clinical Outcomes Compared with Nesiritide Therapy for Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis.Potential beneficial effects of sacubitril-valsartan in renal disease: a new field for a new drug.Current and future uses of nesiritide.
P2860
Q24194433-C47E7593-0916-47E3-B2FC-2F665D474FD5Q24245105-FEE78C72-1DAC-43FA-825D-AD6AD8E92786Q28078389-7322D1DD-2C5F-4628-A6DC-4286C4CDE44BQ28088583-234883C5-E9D6-4623-B1A9-887CCD50F2E2Q33659469-7F09AB12-D849-41C9-BCCC-58D78ABDE390Q33685748-D794F4E6-6CCF-4AF0-86D6-E47056B585F5Q33878162-C1A5C8AD-9174-43DA-B0D0-4716EF8499B0Q34297057-CDF295FB-A39D-4061-8229-2FDDA62C2D45Q34304189-8F5961C5-EC4E-4658-8C05-E2819B0E6657Q34796529-97174405-02B6-4914-A75D-F8A4A0CE3A28Q34859064-B61E7CB6-1D4D-4164-997B-9D10546CA244Q35046791-8B6552CD-0759-4ACF-A518-C16F3DE9AF96Q35054263-B08E58C2-DE3A-4D07-91CC-F7D5E5CB57DAQ35077700-9B11CE28-DA1E-42D7-A4A8-B14C7DDD289FQ35110409-88363A5D-AE85-4527-9239-C526B2C4416BQ35110636-26A3EF9D-5743-40E6-8A19-5A007C131942Q35132420-BF7A4D53-DD8E-4DB6-B968-E63B304C79D7Q35194984-EEF87015-55BE-424C-989F-7DD0434BF7B3Q35200873-7814EBBF-6D09-4A8A-8759-A8EC4D3269C1Q35561935-2AE53EF8-0A77-4689-805D-64CD4B9BA394Q35574016-03860BF2-F03B-4D1F-8D7F-C65B1AE68E57Q35675111-3620F757-EF61-46AA-AE6F-CE6014B59566Q35684955-CC3110A2-1B7E-4450-85A5-F0625B5B1B8FQ35779102-BBC3695C-250E-46E4-80ED-F6559DA6A9F3Q35927894-95B75A2C-7C0C-4D3A-AE2B-D97A996ABE99Q35987052-9E6F2525-1A33-4B0C-9144-5B095B814E20Q36050481-CB76895F-32D4-47DF-B4A6-0509E4C5D2E7Q36266039-482161A1-900E-439D-BF07-3D5A4AB842BEQ36266387-7921C559-F459-4F7C-8999-FE9A1804DEDBQ36382621-75D6F9B1-8242-4A9B-894B-45FBC7F64C84Q36410248-200BF899-0B76-43EE-AE83-EFE195BD8D90Q36603228-22CE9EFA-D202-4A17-9DDB-05BDB269B095Q37298343-C95DA287-5FA6-4757-972E-71D7E5845D38Q37329788-7BC531BC-4EB9-4DA3-BA9E-AF8C7EEEC809Q37390754-BBF52988-1DB7-40B4-B068-73A23326B1DDQ37755096-7D847268-1F4C-4586-9986-1755ECEC88D2Q37941602-F2D57199-22A9-4194-B777-2E4FB2CDCD44Q38540286-DC065280-1286-4847-B874-F451F5D09121Q38847918-4696C505-F2BD-439E-AD28-221FD100F03BQ40442907-DA3F305D-0B3B-4781-B9AD-8B224F0B4D92
P2860
Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Effect of nesiritide versus do ...... y decompensated heart failure.
@en
Effect of nesiritide versus do ...... y decompensated heart failure.
@nl
type
label
Effect of nesiritide versus do ...... y decompensated heart failure.
@en
Effect of nesiritide versus do ...... y decompensated heart failure.
@nl
prefLabel
Effect of nesiritide versus do ...... y decompensated heart failure.
@en
Effect of nesiritide versus do ...... y decompensated heart failure.
@nl
P2093
P1476
Effect of nesiritide versus do ...... y decompensated heart failure.
@en
P2093
Darlene P Horton
Jalal K Ghali
Marc A Silver
Uri Elkayam
P304
P356
10.1016/S0735-1097(01)01818-6
P407
P577
2002-03-01T00:00:00Z